Subject: Re: Novo Nordisk $NVO. (x-post)
https://www.nbcnews.com/health...

"FDA approves weight loss pill from Eli Lilly

Foundayo will be offered in six doses, with patients typically starting on the lowest dose and working their way up to reduce side effects. It can be taken at any time of day without meal restrictions — unlike the Wegovy pill, which must be taken on an empty stomach each morning.

Lilly also has another GLP-1 drug in development, called retatrutide, which has shown greater weight loss in trials than any other drug on the market."